Positively charged amino acids at the interface between α-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase

被引:29
作者
Blom, AM [1 ]
Zadura, AF
Villoutreix, BO
Dahlbäck, B
机构
[1] Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Clin Chem, S-20502 Malmo, Sweden
[2] Univ Paris 05, INSERM, U428, F-75006 Paris, France
关键词
D O I
10.1016/S0161-5890(00)00059-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C4b-binding protein (C4BP) is an abundant and potent down-regulator of complement activation. In its presence, the assembly of the classical pathway C3-convertase is prevented and its natural decay is accelerated. C4BP also acts as a cofactor to the serine proteinase factor I in the cleavage of C4b. C4BP contains repeats of small structural domains: complement control protein (CCP) modules. Previously, we constructed and purified nine recombinant C4BP molecules in which solvent exposed positively charged amino acids at the interface between CCP1 and CCP2 were mutated to polar glutamines. Several of these mutants showed lower binding ability for C4b. In the present investigation, the collection of mutants was tested with functional assays and we found a correlation between changes in the apparent affinity of C4BP mutants for C4b and their ability to down regulate the C3-convertase. Mutagenesis of R-39, K-63, R-64 and particularly H-67 resulted in impaired C4b binding paralleled by lost ability of the C4BP mutants to prevent C3-convertase assembly and to increase the decay rate of the C3-convertase. Furthermore, these amino acids were found to be crucial for the factor I cofactor activity of C4BP in fluid phase degradation of C4b. In conclusion, a cluster of positively charged amino acid residues at the CCP1-CCP2 interface is identified as functionally important in the regulation of the C3-convertase by C4BP. (C) 2000 Elsevier Science Ltd. Ail rights reserved.
引用
收藏
页码:445 / 453
页数:9
相关论文
共 43 条
  • [1] Accardo P, 1996, J IMMUNOL, V157, P4935
  • [2] INHIBITION OF COMPLEMENT COMPONENTS C3 AND C4 BY CADRALAZINE AND ITS ACTIVE METABOLITE
    ANDERSSON, M
    HANSON, A
    ENGLUND, G
    DAHLBACK, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 261 - 265
  • [3] SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR-MAGNETIC-RESONANCE
    BARLOW, PN
    STEINKASSERER, A
    NORMAN, DG
    KIEFFER, B
    WILES, AP
    SIM, RB
    CAMPBELL, ID
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (01) : 268 - 284
  • [4] Berggard K, 1997, INFECT IMMUN, V65, P3638
  • [5] Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins
    Blom, AM
    Berggård, K
    Webb, JH
    Lindahl, G
    Villoutreix, BO
    Dahlbäck, B
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (10) : 5328 - 5336
  • [6] A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function
    Blom, AM
    Webb, J
    Villoutreix, BO
    Dahlbäck, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19237 - 19245
  • [7] BORSOS T, 1961, J IMMUNOL, V87, P326
  • [8] PURIFICATION OF THE HUMAN-COMPLEMENT CONTROL PROTEIN C3B INACTIVATOR
    CROSSLEY, LG
    PORTER, RR
    [J]. BIOCHEMICAL JOURNAL, 1980, 191 (01) : 173 - 182
  • [9] DEGRADATION OF HUMAN-COMPLEMENT COMPONENT-C4B IN THE PRESENCE OF THE C4B-BINDING PROTEIN PROTEIN-S COMPLEX
    DAHLBACK, B
    HILDEBRAND, B
    [J]. BIOCHEMICAL JOURNAL, 1983, 209 (03) : 857 - 863
  • [10] DAHLBACK B, 1984, J BIOL CHEM, V259, P1631